Drugs & Targets Foundation Medicine and EORTC collaborate comprehensive genomic profiling February 09, 2018Vol.44 No.06
Drugs & Targets Abbott PathVysion HER-2 DNA Probe assay to be used in ANGLE study February 09, 2018Vol.44 No.06
Drugs & Targets FDA approves lutetium Lu 177 dotatate for treatment of GEP-NETS February 02, 2018Vol.44 No.05
Drugs & Targets Amgen receives CHMP positive opinion to add updated survival data to Kyprolis label February 02, 2018Vol.44 No.05
Drugs & Targets Syndax announces immuno-oncology collaboration with AstraZeneca February 02, 2018Vol.44 No.05
Drugs & TargetsFree Foundation Medicine and Pfizer form partnership to develop companion diagnostics January 19, 2018Vol.44 No.03
Drugs & TargetsFree FDA approves addition of overall survival data to Kyprolis January 19, 2018Vol.44 No.03
Drugs & TargetsFree Novartis granted FDA Priority Review for Kymriah for adults with r/r DLBCL January 19, 2018Vol.44 No.03
Drugs & TargetsFree FDA expands indications for AZ’s Lynparza, making it first treatment for breast cancer with BRCA mutation January 12, 2018Vol.44 No.02
